Back

Gender differences in clinical profiles, management, and outcomes of valvular heart disease: insights from a nationwide cohort

1 September 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Does age and sex matter for valvular disease? Clinical ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Hongli Ma

Beijing (China)

7 More presentations in this session

Presentation thumbnail
TAVI in very elderly patients: long-term outcomes in a real-world cohort
Doctor N. Carrabba (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Do women fare better in tricuspid regurgitation? Unveiling the gender advantage in tricuspid valve disease
Mrs R. Hinojar Baydes (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Sex differences in pacemaker implantation, ischemic stroke, and mortality after transcatheter aortic valve implantation: a Danish nationwide study
Ms H. Vistisen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Sex-based differences after aortic valve surgery for infective endocarditis: a SWEDEHEART study
Doctor L. Bearpark (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
The relaionship of frailty indices on survival in elderly patients with severe valvular heart diseases
Doctor C. Jiang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Does age and sex matter for valvular disease?

The Event

Event poster

ESC Congress 2025

1 September 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Sex related differences in frequency, management and outcome of severe native valvular heart disease. Results from the ESC-EORP Valvular Heart Disease II survey
thumbnail
Congress Session
Young Investigator Award Session in Valvular Heart Disease
thumbnail
Congress Presentation
Gender-differences in Polyvascular disease: implications for lipid-lowering management and cardiovascular outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources